The global cannabis sector has moved from experiment to enterprise. What began as a patchwork of early medical markets now operates at international scale, shaped by regulation, investment, and public demand. Yet, as the industry matures, its exposure to operational, financial, and reputational risk has become clearer.

Relm has seen this evolution up close. As the only insurer entirely dedicated emerging industries like cannabis, Relm has underwritten through the sector’s growing pains and watched risk management become the measure of long-term stability. Operators that prioritise governance, compliance, and transparency, not only protect their balance sheets, but also build the trust needed for sustained growth.

This Relm Risk Briefing: Cannabis 2026 shares learnings from that experience. It investigates how regulation, insurance, and operational practice intersect across the global supply chain, drawing on data and conversations with market leaders who are setting new standards in safety, sustainability, and accountability.